Jump to navigation
Applications and Technology
Solving the challenges of targeted and tuned expression through synthetic promoters and enabling the next generation of cell and gene therapies.
Improving biomanufacturing through synthetic promoters tailored to specific producer cell lines, viral vector and recombinant proteins.
Synpromics has developed PromPT®, its multi-dimensional bioinformatics engine and DNA assembly platform.
News & Events
2nd Oct to 4th Oct 2019
Carlsbad, CA, US
Synpromics is now a part of the AskBio family of companies
Today marks a major step forward in the evolution of AAV gene therapeutics and the world's most significant gene therapy platform.
Read the news